TAK

TAK Operating Expenses

¥2.24TTTM · JPY

Period ending:

TAK FY Operating ExpensesJPY
TAK FY Operating Expenses2000-03-31: ¥319.36B2001-03-31: ¥353.37B2002-03-31: ¥385.96B2003-03-31: ¥435.05B2004-03-31: ¥445.40B2005-03-31: ¥458.50B2006-03-31: ¥527.30B2007-03-31: ¥567.01B2008-03-31: ¥673.05B2009-03-31: ¥942.33B2010-03-31: ¥760.69B2011-03-31: ¥734.72B2012-03-31: ¥810.71B2013-03-31: ¥987.13B2014-03-31: ¥1.06T2015-03-31: ¥1.39T2016-03-31: ¥1.14T2017-03-31: ¥1.02T2018-03-31: ¥1.03T2019-03-31: ¥1.28T2020-03-31: ¥2.10T2021-03-31: ¥1.69T2022-03-31: ¥2.00T2023-03-31: ¥2.29T2024-03-31: ¥2.62T2025-03-31: ¥2.66T2026-03-31: ¥1.87T¥2.66T¥0.00
2000-03-312026-03-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in JPY. Dates are period ends; a fiscal year may differ from a calendar year.

TAK operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 27 observations from Mar 31, 2000 to Mar 31, 2026.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) Operating Expenses — Annual fiscal periods (JPY)
Period endingOperating Expenses (JPY)
1,866,289,192,000
2,658,748,000,000
2,618,182,000,000
2,292,900,000,000
2,001,315,000,000
1,694,235,000,000
2,101,016,000,000
1,277,169,000,000
1,032,821,000,000
1,017,429,000,000
1,141,145,000,000
1,386,088,000,000
1,062,149,000,000
987,134,000,000
810,711,000,000
734,719,000,000
760,690,000,000
942,325,000,000
673,048,000,000
567,005,000,000
527,296,000,000
458,503,000,000
445,403,000,000
435,051,000,000
385,963,000,000
353,365,000,000
319,356,000,000

Compare operating expenses

All TAK financial metrics · TAK stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.